bosentan anhydrous has been researched along with Hyperglycemia, Postprandial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsaid, M; Coucha, M; Ergul, A; Kaczmarek, J | 1 |
1 other study(ies) available for bosentan anhydrous and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control.
Topics: Animals; Bosentan; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Hyperglycemia; Middle Cerebral Artery; Neovascularization, Pathologic; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Vascular Remodeling | 2014 |